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Several possible sources of discrepancies
between hybridization results can be identi-
fied using different gene array platforms.
Among these are differences in low-end
sensitivity, dynamic range, and linearity
(Aach et al. 2000). Such differences are
likely to influence the magnitude of gene
expression but not account for qualitative
shifts from induction to repression
reported by two different hybridization
platforms. Discrepancies in the absolute
values reported for induction or downregu-
lation may simply result in differences in
the statistical significance of a set of
hybridization results, but a qualitative shift
from induction to repression in the results
reported from two different hybridization
platforms can lead to an incorrect
biological interpretation (Kuo et al. 2002).
A cDNA hybridization platform
(NIEHS; National Institute of Environ-
mental Health Sciences, Research Triangle
Park, NC) and the Affymetrix (Santa
Clara, CA; http://www.affymetrix.com/)
synthetic oligo hybridization platforms
were used in a series of rat toxicogenomic
studies coordinated by the International
Life Sciences Institute (ILSI) Health and
Environmental Sciences Institute (HESI)
(Ulrich et al. 2004). One of these studies
evaluated the effects of methapyrilene on
rat hepatic gene expression as measured by
both cDNA and synthetic oligo hybridiza-
tion platforms. The results of the NIEHS
cDNA platform for caldesmon in these
studies showed a decrease (Hamadeh et al.
2002) in gene expression levels for the
high-dose methapyrilene 7-day pooled
samples compared with their controls.
However, the Affymetrix platform showed
increases (Waring et al. 2004) in expression
levels for caldesmon in these samples.
Quantitative reverse transcription–
polymerase chain reaction (qRT–PCR) is a
gene expression measurement platform that
can be used to independently assess dis-
crepancies between different hybridization
platforms reported for specific genomic
sequences. This platform is considered a
“gold standard” for its analytical sensitivity,
dynamic range, and linearity of gene
expression measurements (Bustin 2000;
Dooley et al. 2003). Multiple primer pairs
were designed to probe speciﬁc sections of
genomic sequences for caldesmon to help
identify the reason for the discrepant
hybridization results. We show here the
results of our analysis with qRT–PCR.
Materials and Methods
RNA samples and conversion to cDNA.
Pooled RNA samples were obtained from
the methapyrilene study as described in
Waring et al. (2004). Total RNA was con-
verted to cDNA with the RT–PCR
Miniprep Kit (Applied Biosystems, Palo
Alto, CA).
Real-time PCR analysis of gene expres-
sion. Primers (Table 1) for the high effi-
ciency detection of rat caldesmon mRNA
and 18S ribosomal RNA were designed
using Primer Express (Applied Biosystems,
Foster City, CA). Primer pairs were selected
with a single peak in the melting curve of
the resulting PCR products. Real-time PCR
data and analyses were collected on an
Applied Biosystems 7700 Sequence
Detection System instrument. These data
were analyzed using the comparative CT
method as described in the instructions of
the ABI PRISM 7700 User Bulletin #2
(P/N 4303859) from Applied Biosystems.
The amount of each amplicon was normal-
ized to an endogenous control (18S RNA)
whose expression was proportional to the
total amount RNA in each sample.
Results
The UniGene (http://www.ncbi.nih.
gov/UniGene/) sequence for caldesmon
used in the assembly of the NIEHS cDNA
chip is shown in Figure 1. The NIEHS chip
used in the studies reported by Ulrich et al.
(2004) included other sequences identiﬁed
by the same UniGene number Rn.33965
and NIEHS accession number AI044091.
Sequences with this UniGene accession
number are shown in Table 2 with their
corresponding unique Affymetrix ID
(http://www.affymetrix.com), reference
sequences and descriptions, and their
GenBank accession numbers (http://www.
ncbi.nih.gov/GenBank). The GenBank
accession numbers in this table correspond-
ing to caldesmon are AL180288 and
U18419. The other GenBank accession
numbers listed in this table correspond to
rat alpha-2 microglobulin (X14552,
J00738). Each Affymetrix reference
sequence aligns with the sequence corre-
sponding to its GenBank accession number,
and no homology was found between
sequences corresponding to these accession
numbers (data not shown).
The UniGene accession number
sequence AI044091 differs from U18419
in the addition of 74 bp to the original
U18419 sequence between positions 276
and 351 (Figure 1). This 74-bp sequence
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Differences in hybridization platforms used in gene array analysis experiments can lead to signiﬁ-
cant differences in hybridization results. In this study we used quantitative reverse
transcription–polymerase chain reaction (qRT–PCR) to investigate discrepant results between the
National Institute of Environmental Health Sciences cDNA and Affymetrix oligo platforms used
to evaluate hepatic gene expression changes in rats exposed to methapyrilene. Caldesmon cDNA
platform hybridization results showed decreases in gene expression levels for the high-dose
methapyrilene 7-day pooled samples compared with their controls. By contrast, the Affymetrix
oligonucleotide platform showed increases in expression levels for these samples. Quantitative
gene expression measurements provide an explanation for the discrepancies observed for these
samples. In the case of caldesmon, there is a 74-base sequence in the cDNA clone that is absent in
the Affymetrix sequence. The amplicon based on the cDNA clone shows > 100-fold suppression
relative to the day 7 high-dose methapyrilene-pooled control. These data demonstrate the impor-
tance of using a “gold standard,” such as qRT-PCR to conﬁrm key hybridization results as well as
to understand the sources of discrepancies resulting from different hybridization platforms.
Key words: cDNA arrays, gene expression, oligo arrays, quantitative real-time PCR, toxicoge-
nomics. Environ Health Perspect 112:456–459 (2004). doi:10.1289/txg.6695 available via
http://dx.doi.org/ [Online 15 January 2004]is completely homologous with the
alpha-2 microglobulin accession number
X14552 and J00738 sequences. qRT-PCR
of an amplicon overlapping this 74-bp
sequence, as well as for the alpha-2
microglobulin sequences X14552 and
J00738, showed a substantial reduction
(> 100-fold) in message levels for the day 7
high-dose methapyrilene sample, whereas a
similar analysis of amplicons designed
for the amplification of U18419 and
AL180288 showed induction levels above
5-fold (Figure 2). Data for hybridization
(Waring et al. 2004) and for qRT-PCR
were collected from RNA samples from
pooled replicate rats. An arbitrary thresh-
old value of 1.5 was used for the analysis
of the qRT-PCR data.
Figure 3 shows the baseline expression
for these amplicons relative to U18149. A
comparison of this type is possible for
amplicons such as these designed for similar
PCR efficiencies and amplified in similar
chemical matrices. These data show differ-
ences of 10- to 100-fold for the alpha-2
microglobulin amplicons compared with
the caldesmon amplicons.
Discussion
The analysis of discrepancies in hybridization
results between platforms requires knowl-
edge of the original sequences used on each
chip platform as well as independent conﬁr-
mation using a gold standard such as quanti-
tative PCR. The results of this analysis for
the caldesmon discrepancy associated with
the studies reported by Ulrich et al. (2004)
show how these differences may be resolved.
In this case the inclusion of a 74-bp sequence
in the UniGene caldesmon sequence
(Figure 1) accounted for the measurement of
an incorrect caldesmon message. Although
this sequence analysis showed how the
sequences differed from each other, further
analysis with qRT-PCR demonstrated how a
discrepant result between expression changes
measured by the cDNA and Affymetrix
platforms was actually obtained.
qRT-PCR data in Figures 2 and 3
suggest a possible explanation for the dis-
crepancy between the NIEHS and
Affymetrix platform results for the day 7
high-dose methapyrilene sample. Results in
Figure 2 indicate that the message level for
the amplicon corresponding to the 74-bp
sequence was reduced by > 100-fold
compared with its baseline expression level.
This reduction in message level was also
observed for the amplicons in the alpha-2
microglobulin accession number X14552
and J00738 sequences. However, amplicons
in the caldesmon sequences with accession
numbers U18419 and AL180288 both
show detectable levels (> 1.5-fold) of induc-
tion as a result of methapyrilene treatment.
Results in Figure 3 show that baseline
expression levels for the 74-bp and
alpha-2 microglobulin amplicons were
10- to 100-fold higher than the corre-
sponding levels for the caldesmon ampli-
cons. These data predict that the NIEHS
cDNA chip would show a significant
reduction in expression level for the
hybridization of caldesmon with the
74-bp additional sequence as well as for
the alpha-2 microglobulin sequences that
were incorrectly labeled in this platform
as caldesmon (Figure 3). Not only would
we expect a significant reduction in
expression levels, but this reduction
would also occur from baseline expression
levels at least an order of magnitude
higher than those for the true caldesmon
sequence.
Affymetrix caldesmon probe sequences
were homologous with sequences for
accession numbers U18419 and AL180288.
These sequences correctly probe expression
levels for the caldesmon gene. Affymetrix
probes for the alpha-2 microglobulin
sequences with accession numbers X14552
and J00738 were reported (Waring et al.
2004) to have reduced expression levels
(5- and 7-fold, respectively) for the day 7
high-dose methapyrilene sample compared
with its baseline expression levels.
Other artifacts can lead to discrepancies
between the results reported by different
hybridization platforms. The studies
reported by Ulrich et al. (2004) had a simi-
lar discrepant result for PCTAIRE expres-
sion. This particular result was traced to a
UniGene sequence for this gene that was
the reverse complement of the original
sequence (data not shown). In this example
where the sequence is completely reversed,
accurate hybridization results would not
be possible.
The results presented by Ulrich et al.
(2004) reported a discrepant call level of
approximately 5% between the Affymetrix
and cDNA platforms. Analysis of all of
these discrepancies is beyond the scope of
the present report. However, it is clear that
such an analysis is essential at least for indi-
vidual gene expression results that are used,
for example, for the assembly of mechanis-
tic models of toxicity or for the identiﬁca-
tion of genomic biomarkers of toxicity.
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Table 1. Sequences for primers of amplicons tested.
GenBank accession no.a Sequence Forward primer Reverse primer
AI044091 UniGene caldesmon CCATTAAGCACTTCTTGGATTGACT GCCTCCAGAGTGCCTCTCTGT
AI180288 Caldesmon TCATGTTTCTGCACTTTAGACTAAAGC TGCCTACTTAGATAATTTCTTCCATGCT
U18419 Caldesmon CACTGACCACGTCCATTCCTT CTGGTCAGTGCATGCGTTTATAA
X14552 Alpha-2-microglobulin GACCCCTCTTTCCCATTTCC GACTTTCATACATTGCCTGAGTGAAG
J00738 Alpha-2-microglobulin AGTGCCTCTCTGTCCAGAAGTCA GAACCCATTAAGCACTTCTTGGAT
aFrom GenBank (http://www.ncbi.nih.gov/GenBank/).
Figure 1. Sequence for UniGene accession number AI044091 (UniGene Rn.33965). The 74-bp sequence insert
highlighted in this sequence runs from 276 to 351 bp. From UniGene (http://www.ncbi.nih.gov/UniGene/).Mini-Monograph | Goodsaid et al.
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Table 2. Affymetrix sequences with caldesmon UniGene accession number.
UniGene NIEHS GenBank 
IDa accession no.b Affymetrix IDc accession no.d Affymetrix sequences Affymetrix description
Rn.33965 Al044091 rc_AI180288_s_at AI180288 CAGACATCATGTTTCTGCACTTTAGACTAA EST224031 Rattus norvegicus cDNA,
AGCATGGAAGAAATTATCTAAGTAGGCAA 3‘ end /clone=RSPCS84 /clone_end=3‘ 
TCAAAATTCTCTGAAAGTGATCCACTTCAG /gb=AI180288 /µg=Rn.10621 /len=417
ATCTGATATAGGGCAGTGATGATTGTCTTT
TTTTTAAAAAAGAAGATGTACTGTTGACAT
ATTGCTTTTCTTCTATGCTGATTCATACCTA
GATTGGGTGATTATTTTAGCTGACAGTGGT
ACTGATTTTTTTCTTCAGGTTAGTTGCTTTG
TGGATTTCTCTGGT
Rn.33965 Al044091 U18419_at U18419 GGTTATAGCGCATGCACTGACCACGTCCAT Rattus norvegicus nonmuscle caldesmon
TCCTTAACGCTGAGGTTATAAACGCATGCA mRNA, complete cds /cds=(723,2318) 
CTGACCAGCTCCATTCCTTAACCCTGAGGT /gb=U18419 /gi=622966 
TATAGCGAATGCACTGACCAGCTCCATTCC /µg=Rn.10621 /len=5541
TTAACGCTGAGGTTATAGCGCATGCACTGA
CCAGCTCCATTCCTTAACCCTGAGGTTATA
GCGCATGCACTGACCAGCTCCATTCCTTAA
CCCTGAGGTTATAGCGCATGCACTGACCAG
CTCCATTCCTTAACG
Rn.33965 Al044091 X14552_at X14552 GTCTGGAGAGCACACTCCTCTGACCCCTCT Rat salivary gland mRNA for (alpha)2(mu) 
TTCCCATTTCCCAAGACTTCACTCAGGCAA globulin, type 1 /cds=(54,593) 
TGTATGAAAGTCTTTAAAAGTGGCAAGGTT /gb=X14552 /gi=55569 /µg=Rn.10203 
TTCACCATTATTCCTCAAGGCAATGACCAT /len=1710
TCTTCAGAGCTTCTTATGCCGAAGGTTGTG
GAAACAAGCCTCACCTTTCGTTACTTCATT
TTTCATAGGCCTTCCATAAGGAAAGAGTCA
TTTATTCTATGCCTTTCCTCCCTGTTTTCTG
ACAAATAATGTT
Rn.33965 Al044091 J00738_s_at J00738 AGAGTGCCTCTCTGTCCAGAAGTCAATCCA Rattus norvegicus submaxillary gland 
AGAAGTGCTTAATGGGTTCCT alpha-2µ globulin mRNA, complete cds 
/cds=(58,603) /gb=J00738 /gi=204262 
/µg=Rn.10203 /len=1003
aFrom UniGene (http://www.ncbi.nih.gov/UniGene/). bFrom NIEHS (http://dir.niehs.nih.gov/microarray/). cFrom Affymetrix (http://www.affymetrix.com). dFrom GenBank
(http://www.ncbi.nih.gov/GenBank/).
10
1
0.1
0.01
0.001
F
o
l
d
 
c
h
a
n
g
e
13 7
Day
74-bp amplicon
in AI044091
Al180288 (EST)
U18419
X14552
J00738
1,000
100
10
1
B
a
s
e
l
i
n
e
 
p
r
e
v
a
l
e
n
c
e
 
r
e
l
a
t
i
v
e
 
t
o
 
U
1
8
4
1
9
13 7
Day
74-bp amplicon
in AI044091
Al180288 (EST)
U18419
X14552
J00738
Figure 2. Relative quantification of amplicons tested. The graph shows the
fold change relative to basal expression levels in pooled rat liver RNA sam-
ples for the high-dose methapyrilene-pooled rat liver RNA samples from
Waring et al. (2004) for quantitative gene expression of the amplicons
defined by the primers in Table 2. Accession numbers are from GenBank
(http://www.ncbi.nih.gov/GenBank/).
Figure 3. Normalized baseline expression of amplicons tested. The graph shows
the baseline gene expression levels sampled for amplicons defined by the
primers in Table 2. These data have been normalized to 18S total RNA and plot-
ted relative to the baseline expression levels for U18419. Accession numbers
are from GenBank (http://www.ncbi.nih.gov/GenBank/).Mini-Monograph | PCR deconstruction of microarray discrepancies
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